Cắt bỏ hạch lympho gác (Sentinel Lymphadenektomie) trong ung thư tuyến tiền liệt – Tình trạng hiện tại

Allaf ME, Palaputtu GS, Trock BJ et al. (2004) Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172: 1840–1844 Bader P, Burkhard FC, Markwalder R, Studer UE (2002) Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 168: 514–518 Bader P, Spahn M, Woehr M, Frohneberg D (2007) Extent of lymph node dissection in correlation to percentage of detected lymph node metastases and progression. J Urol (Suppl) 177: 463; 1406 Bastide C, Brenot-Rossi I, Garcia S et al. (2004) Feasibility and value of the isotope sentinel node mapping technique in prostate cancer. Prog Urol 14: 501–506 Beri A, Janetschek G (2006) Technology insight: radioguided sentinel lymph node dissection in the staging of prostate cancer. Nat Clin Pract Urol 3: 602–610 Brenot-Rossi I, Bastide C, Garcia S et al. (2005) Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 32: 635–640 Burkhard FC, Schumacher M, Thalmann GN, Studer UE (2005) Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer? BJU Int 95: 275–278 Corvin S, Schilling D, Eichhorn K et al. (2006) Laparoscopic sentinel lymph node dissection – a novel technique for the staging of prostate cancer. Eur Urol 49: 280–285 Daneshmand S, Quek ML, Stein JP et al. (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172: 2252–2255 Fukuda M, Egawa M, Imao T et al. (2007) Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer. J Urol 177: 1313–1317 Ganswindt U, Paulsen F, Corvin S et al. (2007) Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int J Radiat Oncol Biol Phys 67: 347–355 Gould EA, Winship T, Philbin PH, Kerr HH (1960) Observations on a „sentinel node“ in cancer of the parotid. Cancer 13: 77–78 Haas CJ, Wagner T, Wawroschek F, Arnholdt H (2005) Combined application of RT-PCR and immunohistochemistry on paraffin embedded sentinel lymph nodes of prostate cancer patients. Pathol Res Pract 200: 763–770 Häcker A, Jeschke S, Leeb K et al. (2006) Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]Fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 176: 2014–2019 Heidenreich A, Varga Z, Knobloch R von (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167: 1681–1886 Jeschke S, Beri A, Grull M et al. (in press) Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol ■: ■–■ Rudoni M, Sacchetti GM, Leva L et al. (2002) Recent applications of the sentinel lymph node concept: preliminary experience in prostate cancer. Tumori 88: 16–17 Silva N, Anselmi CE, Anselmi OE et al. (2005) Use of the gamma probe in sentinel lymph node biopsy in patients with prostate cancer. Nucl Med Commun 26: 1081–1086 Takashima H, Egawa M, Imao T et al. (2004) Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 171: 2268–2271 Vogt H, Wawroschek F, Wengenmair H et al. (2002) Sentinel lymph node diagnostic in prostate carcinoma: Part I: Technique and clinical evaluation. Nuklearmedizin 41: 95–101 Wawroschek F, Vogt H, Weckermann D et al. (1999) The sentinel lymph node concept in prostate cancer – first results of gamma probe-guided sentinel lymph node identification. Eur Urol 36: 595–600 Wawroschek F, Vogt H, Weckermann D et al. (2001) Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 166: 1715–1719 Wawroschek F, Vogt H, Wengenmair H et al. (2003) Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Urol Int 70: 303–310 Wawroschek F, Wagner T, Hamm M et al. (2003) The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 43: 132–137 Weckermann D, Dorn R, Holl G et al. (2007) Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 51: 1549–1558 Weckermann D, Dorn R, Trefz M et al. (2007) Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol 177: 916–920 Weckermann D, Holl G, Dorn R et al. (2007) Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer. BJU Int 99: 1036–1040 Weiss M, Gildenhaus FJ, Brinkbäumer K et al. (2005) Lymph kinetics with technetium-99m labeled radiopharmaceuticals. Animal studies. Nuklearmedizin 44: 156–165 Wengenmair H, Kopp J, Vogt H et al. (2002) Sentinel lymph node diagnostic in prostate carcinoma: Part II: Biokinetics and dosimetry of 99mTc-Nanocolloid after intraprostatic injection. Nuklearmedizin 41: 102–107